Guardant Health
GH
#2609
Rank
โ‚น458.17 B
Marketcap
โ‚น3,554
Share price
-4.25%
Change (1 day)
126.76%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Net assets

Net assets on the balance sheet as of December 2024 : -โ‚น12.19 Billion

According to Guardant Health 's latest financial reports the company has -โ‚น12.19 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Guardant Health - Net assets on balance sheet (from 2017 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$โ‚น13.21 B165.27%
2022-12-31$โ‚น4.97 B-89.63%
2021-12-31$โ‚น48.00 B-51.58%
2020-12-31$โ‚น99.14 B63.95%
2019-12-31$โ‚น60.47 B64.74%
2018-12-31$โ‚น36.70 B86.28%
2017-12-31$โ‚น19.70 B263.84%
2016-12-31$โ‚น5.41 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
โ‚น76.64 B-729.10%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น232.86 B-2,011.30%๐Ÿ‡บ๐Ÿ‡ธ USA